Dr. Danielle Renee Sterrenberg, MD

Dr. Sterrenberg practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Sterrenberg's NPI, 1023243748, was assigned on May 26, 2009. Dr. Sterrenberg graduated from University of Arkansas For Medical Sciences College of Medicine in 2009. Dr. Sterrenberg's California license number on file is C175342.

Dr. Sterrenberg's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Sterrenberg's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Sterrenberg is also affiliated with Huntington Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Sterrenberg to 2 more hospitals, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sterrenberg practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sterrenberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sterrenberg is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sterrenberg's licenses on file in 3 states: California, Illinois and Indiana.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and lung cancer among the conditions Dr. Sterrenberg treats.

CMS data shows 1,506 Medicare services from Dr. Sterrenberg across 5 procedure codes in 2024, for 337 Medicare patients. Medicare paid $107,524 for them.

CMS counts 337 Medicare patients who saw Dr. Sterrenberg in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have cancer, and 72% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sterrenberg's median patient age at 72, with 90% women.

In 2024, Dr. Sterrenberg wrote 726 Medicare Part D claims for 169 patients. 72% of them were for generic drugs. CMS names the drug for 510 of them, across 18 drugs with 11 or more claims each, at $1,859,505 in total drug cost. In 2023, CMS named 455 claims across 15 drugs.

Dr. Sterrenberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sterrenberg as offering telehealth.

Dmand AI links 1 paper to Dr. Sterrenberg in 2016. Dr. Sterrenberg's most frequent co-authors are Parameswaran N. Hari, MD, Tulio E. Rodriguez, MD and Scott E. Smith, MD, PhD.

Dmand AI links Dr. Sterrenberg to 9 clinical trials, 3 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Ductal and Neoplasm Metastasis. Alliance for Clinical Trials in Oncology sponsors the most, 2. Open Payments lists research payments to Dr. Sterrenberg that name 1 trial.

CMS Open Payments shows 276 general payments to Dr. Sterrenberg from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Puma Biotechnology, Inc. paid the most, $110,121. It also lists 2 research payments totaling $1,795 from 2020 to 2022, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Sterrenberg, most recently Magis Star in 2013.

Dr. Sterrenberg graduated from University of Arkansas For Medical Sciences College of Medicine in 2009. Dr. Sterrenberg is a member of AOA, ASCO and ASH.

Dr. Sterrenberg is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.